CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling (Q44131260)
Jump to navigation
Jump to search
scientific article published on 21 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling |
scientific article published on 21 November 2011 |
Statements
1 reference
CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling (English)
1 reference
1 reference
1 reference
1 reference
G Gerken
1 reference
A Katsounas
1 reference
M Trippler
1 reference
B Wang
1 reference
S Kottilil
1 reference
21 November 2011
1 reference
1 reference
19
1 reference
2
1 reference
128-137
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference